← Eichor
Condition: Chronic Hbv Infection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Chronic Hbv Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study）
NA · 1 location(s) · Qing XIe · NCT06323681The Establishment of Korean Hepatitis B Patients Cohort
Phase N/A · 1 location(s) · Yonsei University · NCT04139850Sequential PEG-IFN for HBV After Ending RNA-targeted Regimens
NA · 2 location(s) · Huashan Hospital · NCT06923280Combined Use of Bacteroides Fragilis and BCAAs on HBsAg Clearance
Phase N/A · 1 location(s) · First Affiliated Hospital of Fujian Medical University · NCT07257562Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B
Phase 1 · 3 location(s) · Tune Therapeutics, Inc. · NCT06671093Evaluation of Patients With Liver Disease
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT00001971Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Part
Phase 1 · 2 location(s) · Aligos Therapeutics · NCT07342881New HBV Infection Biomarkers: Clinical Characterization and Impact on Management
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06906016A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B
Phase 2 · 34 location(s) · Ausper Biopharma Co., Ltd. · NCT07635186Gene Discovery in CHB Patients to Identify Unknown Pathways That Lead to B and NK Cell Deregulation
NA · 3 location(s) · University Hospital, Limoges · NCT06853886A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mil
Phase 1 · 5 location(s) · Ausper Biopharma Co., Ltd. · NCT07600788To Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatitis B (CHB)
Phase 3 · 1 location(s) · Fujian Akeylink Biotechnology Co., Ltd. · NCT07090759Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B
Phase N/A · 1 location(s) · Huashan Hospital · NCT04896255Treatment and Prognosis of Patients With Chronic HBV Infection
Phase N/A · 1 location(s) · Xiangya Hospital of Central South University · NCT05392387Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]
Phase 2 · 1 location(s) · University Health Network, Toronto · NCT06216470Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
Phase 4 · 1 location(s) · Mercy Medical Center · NCT04588077Real World Assessment of People Living With Chronic Hepatitis B in Australia
Phase N/A · 19 location(s) · Kirby Institute · NCT04914611Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance
Phase N/A · 1 location(s) · Beijing Friendship Hospital · NCT06779864TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate
Phase 1/Phase 2 · 6 location(s) · Michael Hoelscher · NCT06513286A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)
Phase 2 · 1 location(s) · Ausper Biopharma Co., Ltd. · NCT07137910HepB mAb19 in Individuals With Chronic Hepatitis B Infection
Phase 1 · 2 location(s) · Rockefeller University · NCT05856890Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody (The SAMBA Study)
Phase 1 · 1 location(s) · Aarhus University Hospital · NCT06668727Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b
Phase N/A · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT02883647"Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu
Phase N/A · 6 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT03097952"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chron
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04690972Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase
Phase N/A · 5 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT05661786Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B
Phase 2 · 1 location(s) · Fujian Akeylink Biotechnology Co., Ltd. · NCT07709520Study of LW231 in Participants With Chronic Hepatitis B
Phase 1/Phase 2 · 2 location(s) · Shanghai Longwood Biopharmaceuticals Co., Ltd. · NCT07179575Assessment of Treatment Adherence and Associated Factors in Chronic HepB Patients Supported by HBVCare
NA · 2 location(s) · Institute of Gastroenterology and Hepatology, Vietnam · NCT07540637Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region
Phase 2 · 8 location(s) · AusperBio Therapeutics Inc. · NCT07370207
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.